BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Taisho Pharmaceutical Holdings Co. Ltd.

Headquarters: Tokyo, Japan
Year Founded: 1912
Status: Public
Industry Sector: HealthTechnology
CEO: Error During Calculation
Number Of Employees: 8,784
Enterprise Value: $1,669,966,650
PE Ratio: 83.62
Exchange/Ticker 1: JASDAQ:4581
Exchange/Ticker 2: N/A
Latest Market Cap: $167

BioCentury | Nov 10, 2021
Management Tracks

Wandeler to leave MorphoSys

Plus: Rubius, AstraZeneca, Landos, Nyxoah, Progenity and more
BioCentury | Dec 23, 2020
Deals

Insilico caps year of deals by opening its computational platforms to pharmas’ in-house teams

Insilico is getting pharmas behind the wheel of its target, compound discovery tech
BioCentury | Oct 10, 2017
Distillery Therapeutics

Neurology

BioCentury | Aug 8, 2016
Clinical News

Zosyn tazobactam/piperacillin regulatory update

BioCentury | Feb 1, 2016
Clinical News

Boniva ibandronate regulatory update

BioCentury | Dec 7, 2015
Clinical News

Careram regulatory update

BioCentury | Aug 3, 2015
Clinical News

Zosyn tazobactam/piperacillin regulatory update

BioCentury | May 4, 2015
Company News

Vernalis, Taisho Pharmaceutical Holdings deal

Items per page:
1 - 10 of 26